Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Ticker SymbolRVTY
Company nameRevvity Inc
IPO dateAug 12, 2101
CEOSingh (Prahlad R)
Number of employees11000
Security typeOrdinary Share
Fiscal year-endAug 12
Address77 4Th Avenue
CityWALTHAM
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code02451
Phone17816636900
Websitehttps://www.revvity.com/
Ticker SymbolRVTY
IPO dateAug 12, 2101
CEOSingh (Prahlad R)